Back to Market Feed

Product Information

ENTECAVIR 1 MG TABLET is a generic product labeled by Cameron Pharmaceuticals, priced at $0.3658 per EA under NDC 42494045830. Its NADAC has been published 52 times since Aug 27, 2025.

FDA first approved this application on Dec 23, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENTECAVIR 1 MG TABLET

ENTECAVIR ANHYDROUS
$0.3658per EA

Strength

1 mg/1

NDC

42494045830

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ENTECAVIR ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216857

FDA Approved

12/23/2024

TE Code

AB

On Market Since

5/15/2025

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ENTECAVIR 1 MG TABLET has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3658 per EA
All-time high$0.4888 (Dec 10, 2025)
All-time low$0.3119 (Feb 18, 2026)
52-week high$0.4888
52-week low$0.3119
Median price$0.3632
Average price$0.3882
Largest weekly change-19.0% (Jan 21, 2026)
Weeks tracked52
Tracking sinceAug 27, 2025

Price History

1W

+3.9%

1M

+3.9%

3M

+1.4%

6M

+17.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-18.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ENTECAVIR ANHYDROUS market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

ACYCLOVIR 200 MG/5 ML SUSP
Generic
00472008216•Actavis Pharma, Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
31722068147•Camber Pharmaceuticals Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
62135080347•Chartwell RX LLC
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
70954018810•ANI Pharmaceuticals, Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72205017072•Novadoz Pharmaceuticals LLC
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72888007917•Advagen Pharma Ltd.
$0.0694
per ML
ACYCLOVIR 400 MG TABLET
Generic
75834012201•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 400 MG TABLET
Generic
75834012205•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 200 MG CAPSULE
Generic
75834012401•Nivagen Pharmaceuticals Inc.
$0.0971
per EA
ACYCLOVIR 200 MG CAPSULE
Generic
00904578961•Major Pharmaceuticals
$0.0973
per EA

Frequently asked questions

What is the NADAC price of ENTECAVIR 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 1 MG TABLET, manufactured by Cameron Pharmaceuticals, is $0.3658 per EA (NDC 42494045830), effective Aug 19, 2026.

How has the price of ENTECAVIR 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTECAVIR 1 MG TABLET has declined 18.8%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for ENTECAVIR 1 MG TABLET?

Since Aug 27, 2025, the NADAC for ENTECAVIR 1 MG TABLET has ranged from a low of $0.3119 (Feb 18, 2026) to a high of $0.4888 (Dec 10, 2025), with a median of $0.3632 per EA.

Are there cheaper alternatives to ENTECAVIR 1 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ENTECAVIR 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ENTECAVIR 1 MG TABLET?

ENTECAVIR 1 MG TABLET (NDC 42494045830) is labeled by Cameron Pharmaceuticals, and CMS classifies it as a generic product.